Y mAbs Therapeutics
Price & Volume
Stats
See more52W Range | $5.60-$20.90 |
Market Cap | $256.1M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $84.5M |
Revenue Growth (YoY) | -9.7% |
Gross Profit (12 Mos) | $75.1M |
Diluted EPS | -$0.54 |
News
See moreYahoo Finance • 3 days ago
Y-mAbs to Announce Fourth Quarter and Full Year 2024 Financial and Operating Results on March 4, 2025
Yahoo Finance • 17 days ago
Y-mAbs to Present at the Oppenheimer 35ᵗʰ Annual Life Sciences Conference
Yahoo Finance • 23 days ago
Y-mAbs Presents Translational Pharmacokinetics of GD2-SADA from Pretargeted RIT Platform at the SNMMI Mid-Winter and ACNM Annual Meeting
Yahoo Finance • 7 months ago
Y-mAbs Therapeutics, Inc. (YMAB): One of Caligan Partners’ Top Holdings Now?
About
CEO | Mr. Michael Rossi |
CFO | Mr. Peter P. Pfreundschuh CPA |
Address | 230 Park Avenue, New York, NY, United States, 10169 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 100 |
